Login / Signup

Clinical outcomes of assisted reproductive technology treatment by using a self-injection of recombinant human chorionic gonadotropin as the final maturation trigger.

Koji NakagawaMidori ObaKaori EharaNozomi IshigakiNao InoAkiko ItakuraRyo TsutsumiKatsuki NakaoYuko OjiroRikikazu Sugiyama
Published in: Reproductive medicine and biology (2018)
The self-injection of the prefilled r-hCG is a favorable MT for ART patients.
Keyphrases
  • recombinant human
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • combination therapy
  • patient reported